SCHEMBL8912482

SCHEMBL8912482

NC1Cc2ccc(-c3ccc(=O)[nH]n3)cc2C1.O=C(O)Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.43
PDE3B Q13370 5/20 0.43
PDE3A Q14432 5/20 0.43
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
SLC6A3 Q01959 2/20 0.43
PDE4A P27815 3/20 0.42
PDE4B Q07343 3/20 0.42
PDE4C Q08493 3/20 0.42
PDE4D Q08499 3/20 0.42
LMNA P02545 3/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
P2RX7 Q99572 1/20 0.39
GPR119 Q8TDV5 1/20 0.39
KDR P35968 1/20 0.37
TP53 P04637 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8307668 0.92 PDE3B (0.49) CYP1A2PDE3BPDE3ASLC6A2SLC6A4
Bromide SCHEMBL8307460 0.91 PDE3B (0.48) CYP1A2PDE3BPDE3ASLC6A2SLC6A4
SCHEMBL8911980 0.78 PDE3B (0.46) CYP1A2PDE3BPDE3ASLC6A2SLC6A4
Bromide SCHEMBL8300806 0.77 PDE3B (0.45) CYP1A2PDE3BPDE3ASLC6A2SLC6A4
Bromide SCHEMBL8300626 0.75 PDE3B (0.43) CYP1A2PDE3BPDE3ASLC6A2SLC6A4
SCHEMBL8912488 0.75 PDE4A (0.40) CYP1A2PDE3BPDE3ASLC6A2SLC6A4
SCHEMBL8912452 0.74 PDE3B (0.43) CYP1A2PDE3BPDE3ASLC6A2SLC6A4
SCHEMBL8291725 0.73 PDE3B (0.41) CYP1A2PDE3BPDE3ASLC6A2SLC6A4
SCHEMBL8911600 0.72 CA12 (0.52) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL8912517 0.72 PDE4A (0.40) CYP1A2PDE3BPDE3ASLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5605901-A THERAPY FOR GRAM-NEGATIVE BACTERIA, NEPHRITIS TANABE SEIYAKU CO., LTD. (JP) 1997-02-25 US disclosed
US-5543409-A Indane derivatives for treating endotoxin shock and/or nephritis TANABE SEIYAKU CO., LTD. (JP) 1996-08-06 US disclosed